Efficacy and Safety of KH903 Plus FOLFIRI as a Second-Line Treatment in Unresectable Recurrent or Metastatic Colorectal Cancer: A Randomized Phase 2 Study.

Zaltrap (ziv-aflibercept IV) - Sanofi

5-fluorouracil - Generic mfg.

irinotecan - Generic mfg.

Cyramza (ramucirumab) - Eli Lilly

KH903 - Chengdu Kanghong Pharma

Avastin (bevacizumab) - Roche

leucovorin calcium - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/39632230

Jian Li; Jianfeng Zhou; Jiangming Xu; Jieer Ying; Jufeng Wang; Lin Shen; Nong Xu; Rong Wu; Rongbo Lin; Xianli Yin; Xiao Ke; Xiaoping Qian; Y I Ba; Yali Shen; Yanqiao Zhang; Ying Cheng

Dec 5, 2024